INTRODUCTION {#sec1-1}
============

*Caesalpinia bonduc* seeds have been used in the folklore medicine since long time. The use of this plant has been quoted in the Ayurvedic and traditional scriptures.\[[@ref1]\] Plant is reported to have multiple restorative properties like anthelmintic, antibacterial, antidiuretic and recently it has received considerable attention to treat Diabetes.

*C. bonduc* F. (family: Caesalpiniaceae) is a large, scandent, prickly shrub found throughout the hotter and southern parts of India. It is a large straggling, thorny shrub, the branches are armed with hooks and straight, hard yellow prickles. The leaves are compound. The flowers are pale yellow in color, in supra-axillary racemes at the top. The fruits are inflated pods, covered with prickles, 6 cm long, and 1-2 seeds per pod. The seeds are globular, hard, bluish grey in color with a smooth shiny surface.

*C. bonduc* has numerous synonyms like Duhsparsa -- difficult to touch, Kantaki karanja -- having prickles; Vajra bijaka - having hard seeds, Kanta phala -- has fruits covered with prickles, etc. It is attributed to be an aphrodisiac and general tonic helping in the rejuvenation of the body.\[[@ref2]\] The roasted seed powder is used as an antileprotic. The seeds are useful as anti-inflammatory,\[[@ref3]\] antidiabetic, antiperiodic, antipyretic, etc.\[[@ref4][@ref5]\]

The seeds contain various chemical constituents such as furanoditerpene\'s: a-caesalpin, β-caesalpin, γ-caesalpin, δ-caesalpin, ε-caesalpin, and caesalpin --F; fatty acids: palmitic, stearic, octadeca-4-enoic, octadeca-2, 4-dienoic, lignoceric, oleic and linoleic acids, phytosterinin, b-sitosterol, homoisoflavone bonducellin; amino acids: aspartic acid, arginine, and citrulline; carbohydrates: starch and sucrose; β-carotene, glycoside-bonducin, gums, and resins.\[[@ref6]\]

The seeds of *C. bonduc* have been attributed with anti-inflammatory properties in the folklore medicine. The seed oil and the kernel extracts have been screened for anti-inflammatory and antipyretic activity. The terpenoidal and steroidal moieties have been reported from the seed kernels, which may be responsible for the claimed attributes. Till date, there has been no systematic study carried on the seed coat of *C. bonduc* to substantiate these claims.

EXPERIMENTAL {#sec1-2}
============

Plant Material {#sec2-1}
--------------

Seeds of *C. bonduc* were collected from vicinity of Kannur village, Dist. Bijapur, Karnataka, India. Herbarium was preserved and authenticated by Dr. P. S. N. Rao, Deputy Director, Botanical Survey of India, Pune, India (Specimen Voucher No: DMK-281002).

Preparation of the Extract {#sec2-2}
--------------------------

The plant material was dried and seeds were broken so as to separate the kernel and the seed coat. The seed coat was coarsely powdered and extracted with 95% ethanol in a Soxhlet extractor; further, the extract was filtered and concentrated on Rota-evaporator,\[[@ref7]\] to get a sticky reddish brown extract (*C. bonduc* seed coat extract \[CBSCE\]) (yield 12.3% w/w).

Animals {#sec2-3}
-------

The animal use protocol was approved by the SCES' Indira College of Pharmacy, Pune, India (Animal Eths Comm /1265/ac/09/CPCSEA), and was in accordance with international standard on the care and use of experimental animals. Healthy adult Swiss albino mice weighing between 30 and 40 g were used for antinociceptive studies and Wistar albino rats weighing between 120 and 140 g of either sex were used for the anti-inflammatory studies. Animals were housed under standard conditions and were fed ad-libitum with commercial pellet diet and had free access to water.

Extract and Standard Drugs {#sec2-4}
--------------------------

For each model, the animals were divided into four groups of six animals each, the I^st^ group served as Control (Distilled water and 1% CMC), II^nd^ and III^rd^ group animals were treated with CBSCE (200 and 400 mg/kg p.o.), respectively, the IV^th^ group served as standard where Indomethacin (10 mg/kg b.w)\[[@ref8]\] and Pentazocine (10 mg/kg b.w)\[[@ref9][@ref10]\] were administered by the intraperitoneal route and were used as a standard drugs in the anti-inflammatory activity and analgesic activity, respectively.

Screening of Anti-Inflammatory Activity {#sec2-5}
---------------------------------------

Carrageenan-induced paw edema in rats {#sec2-6}
-------------------------------------

In the Carrageenan-induced Paw Edema,\[[@ref11]--[@ref13]\] all the animals received their respective doses at fixed time once daily for 5 days except for the IV^th^ group where the standard drug was injected one hour prior to the administration of carrageenan. On the fifth day, one hour after the drug administration, 0.1 ml Carrageenan (1%) suspended in normal saline was injected into the sub plantar region of the right hind paw.

The paw was immediately immersed in the Plethysmometer\[[@ref14]\] up to the tibiotarsal articulation and the paw volume was measured,\[[@ref15]\] which served as reading for 0 hr. The readings were taken similarly and paw volumes were measured after every 60-minute interval for next four hours. The average paw swelling in the groups of the CBSCE-treated animals were compared with control and that of the Standard group. Mean increase in paw volume was determined and expressed as mean paw displacement volume in ml.

The % inhibition was calculated at the end of fourth hour by the formula\[[@ref16]\]

I = 100 \[1-(a-x)/ (b-y)\]

Where, I is the % inhibition, "a" is the mean volume at time = t of the test group, "x" is the mean volume at time = 0 of the test group, and "b" is the mean volume at time = t of the control group, "y" is the mean volume at time = 0 of the control group.

Egg albumin-induced paw edema {#sec2-7}
-----------------------------

All the animals received their respective doses at a fixed time once daily for 5 days except for the IV^th^ group where the standard drug was injected one hour prior to the administration of albumin. One hour after treatment, edema was induced by injecting fresh egg albumin (0.1 ml, 1% w/v)\[[@ref17][@ref18]\] solution in distilled water subcutaneously in the plantar surface of the right hind paw of all animals. The paw edema was measured at 30-minute interval at start and later on every hour from 1^st^ to 4^th^ hour by Plethysmometer.

The % inhibition was calculated at the end of fourth hour same as above.

Screening of Analgesic Activity {#sec2-8}
-------------------------------

Eddy\'s hot plate test {#sec2-9}
----------------------

Analgesic activity of the extract and Pentazocine was determined by Eddy\'s Hot Plate Test. In all the groups, the basal reaction time was recorded by observing hind paw licking or jump response in animals, when placed on a hot-plate\[[@ref18]\] maintained at constant temperature (55°C). Normally, animals show such response in 6-8 seconds. A cut-off period of 15 seconds was observed to avoid damage to paws. The reaction time of animals on hot plate was recorded at 0, 30, 60, 90, and 120 minutes after the drug administration. Percentage increase in basal reaction time (index of analgesia) at each time interval was calculated.

Tail immersion method {#sec2-10}
---------------------

The basal reaction time was recorded by observing tail flick response\[[@ref19]\] in animals when tail is immersed in water maintained at constant temperature (55°C). Normally, animals show such response in 3 to 5 seconds. A cut-off period of 10 seconds was observed to avoid tissue damage. In all the four groups, the reaction time of animals in hot water was recorded at 0, 30, 60, 90, and 120 minutes after the drug administration. Percentage increase in basal reaction time -- flicking/removal of tail (index of analgesia) at each time interval was calculated.

Statistical Analysis {#sec2-11}
--------------------

Comparison between control and drug-treated groups was made by Students' '*t*' test.

RESULTS {#sec1-3}
=======

Anti-Inflammatory Activity {#sec2-12}
--------------------------

Carrageenan-induced paw edema in rats {#sec2-13}
-------------------------------------

In the control group, all the animals exhibited severe edema formation which lasted for more than 4 hours. It was observed that CBSCE extract at both the doses, i.e., 200 mg/kg as well as 400 mg/kg reduced the inflammation in all the animals \[[Figure 1](#F1){ref-type="fig"}\]. The results clearly indicate that CBSCE extract at a dose of 400 mg/kg was more effective and significant in controlling the inflammation which is clearly reflected in the % reduction in inflammation table \[[Table 1](#T1){ref-type="table"}\]. The CBSCE 400 animals exhibited reduction in inflammation after the 180-minute interval. In comparison to negative control, Standard drug Indomethacin exhibited highly significant action in controlling the edema and severely restricting the inflammation since the onset of inflammation. The % reduction of inflammation in both the groups at 240 minutes was highly significant.
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Egg albumin-induced acute inflammation {#sec2-14}
--------------------------------------

In the case of egg albumin-induced paw edema, the untreated control group exhibited severe edema in all the animals. The CBSCE extract possesses the ability to control acute inflammation \[[Figure 2](#F2){ref-type="fig"}\] at both the doses. After a span of 120 minutes, it shows reversal and the edema decreases thereafter. CBSCE 400 extract is highly efficient in controlling the initial inflammatory response as compared to CBSCE 200 extract which is clearly reflected in the % reduction in inflammation table \[[Table 2](#T2){ref-type="table"}\]. The standard drug (Indomethacin) is highly significant in controlling the inflammation too. The onset of action in the case of the standard drug was within the first 30 minutes, whereas the extract exhibits delayed onset of action after 60 minutes.
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Analgesic Activity {#sec2-15}
------------------

Eddy\'s hot plate method {#sec2-16}
------------------------

Antinociceptive activity of the extract at both the doses and Pentazocine was determined by Eddy\'s Hot Plate Test \[[Figure 3](#F3){ref-type="fig"}\]. The basal reaction time was recorded by observing hind paw licking or jump response. The extract at both the doses exhibited significant analgesic action at 400 mg/kg; the reflex time was enhanced in comparison to 200 mg/ kg. Here too, the extract-treated groups showed delayed onset of action in comparison to the standard drug. The standard drug Pentazocine exhibited the most significant pain-controlling action. The increase in the basal reaction time duration was also high in the standard treated groups in comparison to the extract treated and the control animals.

![Antinociceptive activity by Eddy\'s Hot Plate Method Hind paw licking time in seconds at different time intervals](JAPTR-3-171-g005){#F3}

Tail immersion method {#sec2-17}
---------------------

The basal reaction time was recorded by observing tail flick response in animals when tail is immersed in water maintained at constant temperature (55°C). CBSCE 200 and CBSCE 400 extracts exhibited a comparatively better analgesic action in comparison to untreated animals \[[Figure 4](#F4){ref-type="fig"}\]; there was a gradual increase in the basal reaction time, Pentazocine showed the onset of action at 30 minutes, whereas the onset of action in the extract was observed after 60 minutes. In extract-treated animals, it was noted that the analgesia duration was prolonged in comparison to the standard drug. This could be due to delayed absorption and greater retention time.

![Basal Reaction Time in Tail Flick Method Tail Flick time in seconds at different time intervals](JAPTR-3-171-g006){#F4}

DISCUSSION {#sec1-4}
==========

The *C. bonduc* seeds have been used in the household remedies for the analgesic and anti-inflammatory action. Even the seeds have been administered to infants in a pediatric traditional formulation known as "GUTTI." The earlier studies have proven the significance of *C. bonduc* seed extracts as strong herbal agent possessing various pharmacological actions. It has been proven that the seed kernels posses anti-inflammatory action. The free radical-scavenging action too has been carried out.\[[@ref20]\] The present study demonstrates that oral administration of CBSCE at varied doses produces consistent antinociceptive and anti-inflammatory effects in different models of pain and inflammation. The above results clearly indicate that *C. bonduc* seed coat posses anti-inflammatory action as claimed in folklore medicine. Though anti-inflammatory activity of *C. bonduc* seed kernels has been proven, this work is novel in proving the anti-inflammatory efficacy of the seed coat. The above results substantiate the claims that CBSCE posses significant anti-inflammatory action. Here in our study, it is observed that the inflammation reaches its maximum approximately at 3-hour interval post-treatment, after which it begins to decline. The late phase, which is a complement-dependent reaction, could be due to overproduction of prostaglandin in tissues.\[[@ref21]\]

The central antinociceptive activity of the extract was evaluated by the hot-plate test as it is very effective and particularly is highly sensitive to strong analgesics and causes limited tissue damage. Our study clearly indicates that CBSCE enhances the tolerance to heat and increases the animal\'s reaction time, which reflects good analgesic action against the hot plate. In the case of the Tail flick method, the basal reaction time is increased with CBSCE-treated animals. The extract of the *C. bonduc* seed coat produces analgesia at both the doses and acts as an analgesic agent too. The activity exhibited by the extract of the seed coat can be attributed to the presence of triterpenoidal moieties in the seed coat extract. From the above results in both the models, we suggest that CBSCE has strong peripheral antinociceptive activity.

CONCLUSION {#sec1-5}
==========

The above results confirm that *C. bonduc* seed coat possesses significant anti-inflammatory and analgesic activity. Our studies hereby confirm the traditional claims that seeds of *C. bonduc* possess anti-inflammatory as well as analgesic activity.
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